CN104082751A - Deep sea fish oil soft capsule containing astaxanthin - Google Patents
Deep sea fish oil soft capsule containing astaxanthin Download PDFInfo
- Publication number
- CN104082751A CN104082751A CN201410297613.6A CN201410297613A CN104082751A CN 104082751 A CN104082751 A CN 104082751A CN 201410297613 A CN201410297613 A CN 201410297613A CN 104082751 A CN104082751 A CN 104082751A
- Authority
- CN
- China
- Prior art keywords
- fish oil
- astaxanthin
- soft capsule
- deep sea
- sea fish
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 title claims abstract description 21
- 235000013793 astaxanthin Nutrition 0.000 title claims abstract description 21
- 239000001168 astaxanthin Substances 0.000 title claims abstract description 21
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 title claims abstract description 21
- 229940022405 astaxanthin Drugs 0.000 title claims abstract description 21
- 235000021323 fish oil Nutrition 0.000 title claims abstract description 20
- 239000007901 soft capsule Substances 0.000 title claims abstract description 13
- 235000020673 eicosapentaenoic acid Nutrition 0.000 claims abstract description 13
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 12
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 6
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 6
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 6
- 229940046009 vitamin E Drugs 0.000 claims abstract description 6
- 239000011709 vitamin E Substances 0.000 claims abstract description 6
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 claims abstract description 3
- 229960005135 eicosapentaenoic acid Drugs 0.000 claims abstract description 3
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 claims abstract description 3
- 235000019198 oils Nutrition 0.000 claims abstract description 3
- 239000002775 capsule Substances 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 3
- 239000002994 raw material Substances 0.000 claims description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract description 9
- 230000000694 effects Effects 0.000 abstract description 6
- 108010010803 Gelatin Proteins 0.000 abstract description 4
- 229920000159 gelatin Polymers 0.000 abstract description 4
- 239000008273 gelatin Substances 0.000 abstract description 4
- 235000019322 gelatine Nutrition 0.000 abstract description 4
- 235000011852 gelatine desserts Nutrition 0.000 abstract description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 4
- 239000000463 material Substances 0.000 abstract description 3
- 235000021122 unsaturated fatty acids Nutrition 0.000 abstract description 3
- 150000004670 unsaturated fatty acids Chemical class 0.000 abstract description 3
- 208000024172 Cardiovascular disease Diseases 0.000 abstract description 2
- 241001465754 Metazoa Species 0.000 abstract description 2
- 230000003064 anti-oxidating effect Effects 0.000 abstract description 2
- 208000026106 cerebrovascular disease Diseases 0.000 abstract description 2
- 230000002526 effect on cardiovascular system Effects 0.000 abstract description 2
- 230000036039 immunity Effects 0.000 abstract description 2
- 238000001727 in vivo Methods 0.000 abstract description 2
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 abstract 6
- 235000020669 docosahexaenoic acid Nutrition 0.000 abstract 3
- 229940090949 docosahexaenoic acid Drugs 0.000 abstract 3
- 241000251468 Actinopterygii Species 0.000 abstract 1
- 230000009758 senescence Effects 0.000 abstract 1
- 230000002195 synergetic effect Effects 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 3
- 208000007536 Thrombosis Diseases 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010061216 Infarction Diseases 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008499 blood brain barrier function Effects 0.000 description 1
- 210000001218 blood-brain barrier Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000006931 brain damage Effects 0.000 description 1
- 231100000874 brain damage Toxicity 0.000 description 1
- 208000029028 brain injury Diseases 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000007574 infarction Effects 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 235000012680 lutein Nutrition 0.000 description 1
- 239000001656 lutein Substances 0.000 description 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 1
- 229960005375 lutein Drugs 0.000 description 1
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 1
- 235000013622 meat product Nutrition 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000004382 potting Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 239000003223 protective agent Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention provides a deep sea fish oil soft capsule containing astaxanthin. The deep sea fish oil soft capsule comprises main active components including deep sea fish oil [(containing EPA(Eicosapentaenoic acid) and DHA (Docosahexaenoic acid)] and astaxanthin oil (containing astaxanthin). The deep sea fish soft capsule comprises main auxiliary materials as follows: water, vitamin E, glycerol and edible animal gelatin. According to the fish oil soft capsule, Omega-3 highly unsaturated fatty acid (EPA and DHA) and astaxanthin with strong antioxidation action are effectively combined, and due to further synergistic effect among the components, cardiovascular and cerebrovascular diseases can be effectively prevented, the immunity can be improved, in-vivo free radicals can be removed, and the effect of delaying senescence is achieved.
Description
(1) technical field
The present invention relates to a kind of fish oil soft capsule, especially a kind of deep-sea fish oil soft capsules that contains astaxanthin, belongs to health food technology field.
(2) background technology
At present, along with improving constantly of living standard, people constantly increase the intake of higher fatty acid meat product, incident is the continuous rising of fat content in blood, and the diseases such as the arterial sclerosis causing thus, thrombus, coronary heart disease, affect and have endangered middle-aged and old Health and Living quality day by day.In order to prevent the generation of this type of disease, people start more edible fish oil series products, due to existing various fish oil series products ubiquities on market: active ingredient is simple, functional component content is low, functional component proportioning is unreasonable, cause that product function is single, the shortcoming of DeGrain, be difficult to play desirable prophylactic effect.
(3) summary of the invention
The present invention is in order to make up the deficiencies in the prior art, a kind of deep-sea fish oil soft capsules that contains astaxanthin is provided, main active ingredient is: deep sea fish oil [contain EPA(eicosapentaenoic acid), DHA(DHA)], astaxanthin, major auxiliary burden is water, vitamin E, glycerine and edible animal gelatin.
EPA in deep sea fish oil, DHA composition are a kind of special unrighted acids, and being is of value to the sanguimotor protection factor.EPA can assist to remove and be attached to cholesterol and the harden plaque on vascular wall, reduces Blood Cholesterol level, contributes to keep unobstructed blood to flow, and suppresses undesired blood aggegation, pre-preventing thrombosis generation, stops the generation of apoplexy or miocardial infarction.
Astaxanthin has in vivo remarkable rising HDL and falls the effect of LDL, can be used to prevention of arterial sclerosis, coronary heart disease and ischemic brain damage.Astaxanthin has the activity of very strong inducing cell division, has important immunoregulation effect.Astaxanthin is easy to by blood-brain barrier and cell membrane; can effectively prevent the damage of amphiblestroid oxidation and photosensitive cell; and central nervous system is especially played a protective role to brain, especially more remarkable than lutein for the effect of senile macula retinae sex change.The strong anti-oxidation of astaxanthin may make it become potential bright protective agent, effectively removes the free radical that causes skin aging, stops skin photoage.
Vitamin E can protect highly unsaturated fatty acid (EPA, DHA) not oxidized, extends shelf life of products.The invention has the beneficial effects as follows, this fish oil soft capsule effectively combines ω-3 highly unsaturated fatty acid (EPA, DHA) and astaxanthin, between composition, further acts synergistically, and can effectively prevent cardiovascular and cerebrovascular disease.And can improve immunity, remove interior free yl, play the effect delaying senility.
(4) specific embodiment
1, preparation content: raw material deep sea fish oil, astaxanthin oil, vitamin E is admixed together according to certain formula, stir, the mass percent of content functional component net content is: EPA:30 ~ 35%, DHA:15 ~ 20%, astaxanthin: 1 ~ 3%.。
2, make capsule body material: take edible gelatin, glycerine and pure water as utricule raw material, glycerine and pure water are proportionally injected in glue pot, and heating is stirred to 75 ℃ of left and right, then adds gelatin, continue to stir final vacuum deaeration in 20～30 minutes, make and obtain envelop materials.
3, the content preparing and capsule body are passed through to pelleting, moulding, wash ball, are dried, make finished product deep-sea fish oil soft capsules.
Claims (2)
1. a deep-sea fish oil soft capsules that contains astaxanthin, is characterized in that: the mass percent of capsule 's content raw material is: fish oil [contain EPA(eicosapentaenoic acid), DHA(DHA)]: 80～90%, astaxanthin oil (containing astaxanthin): 10～20%, vitamin E: 1%.
2. a kind of deep-sea fish oil soft capsules that contains astaxanthin according to claim 1, it is characterized in that: the mass percent of capsule 's content functional component is EPA:30 ~ 35%, DHA:15 ~ 20%, astaxanthin: 1 ~ 3%, the vitamin E that all the other compositions are 1% and other the non-functional component in fish oil.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410297613.6A CN104082751A (en) | 2014-06-29 | 2014-06-29 | Deep sea fish oil soft capsule containing astaxanthin |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410297613.6A CN104082751A (en) | 2014-06-29 | 2014-06-29 | Deep sea fish oil soft capsule containing astaxanthin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104082751A true CN104082751A (en) | 2014-10-08 |
Family
ID=51630599
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410297613.6A Pending CN104082751A (en) | 2014-06-29 | 2014-06-29 | Deep sea fish oil soft capsule containing astaxanthin |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104082751A (en) |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106942727A (en) * | 2017-04-20 | 2017-07-14 | 北京市永康年健康科技有限责任公司 | It is a kind of to be used to reduce DHA algal oil product of blood fat and its preparation method and application |
| CN107080769A (en) * | 2017-05-17 | 2017-08-22 | 王茹 | A kind of natural drug for treating various chronic diseases and medical formula food |
| CN107772190A (en) * | 2017-10-19 | 2018-03-09 | 杭州鑫伟低碳技术研发有限公司 | A kind of Astaxanthin In Haematococcus Pluvialis product formula for improving puerpera and infant immunity |
| CN108902430A (en) * | 2018-06-25 | 2018-11-30 | 丁红卫 | A kind of auxiliary conditioning cardiovascular and cerebrovascular disease combined health care products |
| CN109349553A (en) * | 2018-11-29 | 2019-02-19 | 徐州市迪港商贸有限公司 | A kind of astaxanthin flexible glue capsule formula |
| CN109481416A (en) * | 2019-01-02 | 2019-03-19 | 陈丽娟 | A kind of astaxanthin soft capsule |
| CN109770353A (en) * | 2019-02-01 | 2019-05-21 | 李树森 | Deep-sea fish oil soft capsules and preparation method thereof |
| CN109907321A (en) * | 2019-02-15 | 2019-06-21 | 李树森 | A kind of extremely frigid zones deep-sea fish oil soft capsules and preparation method thereof |
| CN113017079A (en) * | 2019-12-24 | 2021-06-25 | 深圳华大生命科学研究院 | Composition with function of delaying body aging and application thereof |
| RU2778561C1 (en) * | 2022-01-18 | 2022-08-22 | Общество С Ограниченной Ответственностью "Корякморепродукт Дв" | Method for obtaining a biologically active additive |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080299187A1 (en) * | 2007-06-01 | 2008-12-04 | Joar Opheim | Substances for Reducing Occurence of Major Cardiac Events in Humans |
| US20110026811A1 (en) * | 2009-07-31 | 2011-02-03 | Hirokazu Kameyama | Image processing apparatus and method, data processing apparatus and method, and program and recording medium |
| CN103156198A (en) * | 2013-04-03 | 2013-06-19 | 上海春芝堂生物制品有限公司 | Fish oil soft capsules and preparation method thereof |
| CN103349289A (en) * | 2013-06-14 | 2013-10-16 | 芜湖市诺康生物科技有限公司 | Preparation method of fish oil soft capsules |
| CN103829234A (en) * | 2013-12-25 | 2014-06-04 | 无锡市天赐康生物科技有限公司 | Health food capable of improving immunity and reducing blood fat and preparation method thereof |
-
2014
- 2014-06-29 CN CN201410297613.6A patent/CN104082751A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080299187A1 (en) * | 2007-06-01 | 2008-12-04 | Joar Opheim | Substances for Reducing Occurence of Major Cardiac Events in Humans |
| US20110026811A1 (en) * | 2009-07-31 | 2011-02-03 | Hirokazu Kameyama | Image processing apparatus and method, data processing apparatus and method, and program and recording medium |
| CN103156198A (en) * | 2013-04-03 | 2013-06-19 | 上海春芝堂生物制品有限公司 | Fish oil soft capsules and preparation method thereof |
| CN103349289A (en) * | 2013-06-14 | 2013-10-16 | 芜湖市诺康生物科技有限公司 | Preparation method of fish oil soft capsules |
| CN103829234A (en) * | 2013-12-25 | 2014-06-04 | 无锡市天赐康生物科技有限公司 | Health food capable of improving immunity and reducing blood fat and preparation method thereof |
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106942727A (en) * | 2017-04-20 | 2017-07-14 | 北京市永康年健康科技有限责任公司 | It is a kind of to be used to reduce DHA algal oil product of blood fat and its preparation method and application |
| CN106942727B (en) * | 2017-04-20 | 2018-05-15 | 北京市永康年健康科技有限责任公司 | It is a kind of to be used to reduce DHA algal oil product of blood fat and its preparation method and application |
| CN107080769A (en) * | 2017-05-17 | 2017-08-22 | 王茹 | A kind of natural drug for treating various chronic diseases and medical formula food |
| CN107772190A (en) * | 2017-10-19 | 2018-03-09 | 杭州鑫伟低碳技术研发有限公司 | A kind of Astaxanthin In Haematococcus Pluvialis product formula for improving puerpera and infant immunity |
| CN108902430A (en) * | 2018-06-25 | 2018-11-30 | 丁红卫 | A kind of auxiliary conditioning cardiovascular and cerebrovascular disease combined health care products |
| CN109349553A (en) * | 2018-11-29 | 2019-02-19 | 徐州市迪港商贸有限公司 | A kind of astaxanthin flexible glue capsule formula |
| CN109481416A (en) * | 2019-01-02 | 2019-03-19 | 陈丽娟 | A kind of astaxanthin soft capsule |
| CN109770353A (en) * | 2019-02-01 | 2019-05-21 | 李树森 | Deep-sea fish oil soft capsules and preparation method thereof |
| CN109907321A (en) * | 2019-02-15 | 2019-06-21 | 李树森 | A kind of extremely frigid zones deep-sea fish oil soft capsules and preparation method thereof |
| CN113017079A (en) * | 2019-12-24 | 2021-06-25 | 深圳华大生命科学研究院 | Composition with function of delaying body aging and application thereof |
| RU2778561C1 (en) * | 2022-01-18 | 2022-08-22 | Общество С Ограниченной Ответственностью "Корякморепродукт Дв" | Method for obtaining a biologically active additive |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104082751A (en) | Deep sea fish oil soft capsule containing astaxanthin | |
| Rizliya et al. | Biological, physical, and chemical properties of fish oil and industrial applications | |
| Asif | Chemical characteristics and nutritional potentials of unsaturated fatty acids | |
| CN107494775A (en) | A kind of edible blend oil and preparation method thereof | |
| CN105238595B (en) | A kind of okra beauty soap and preparation method thereof | |
| CN104055123A (en) | Gamma-linolenic acid containing deep sea fish oil soft capsule | |
| US20180042978A1 (en) | Method of treating photo-induced ocular fatigue and associated reduction in speed of ocular focus | |
| CN103989179A (en) | Deep sea fish oil soft capsule containing ginkgo leaf extract | |
| CN104000208A (en) | Soft deep sea fish oil capsule containing squalene | |
| JP6083942B2 (en) | Composition comprising long life grass and seafood oil | |
| CN101961352A (en) | Self-emulsified fish oil soft capsules without fishy smell | |
| CN103989181A (en) | Walnut oil-containing fish oil soft capsule | |
| CN103989180B (en) | Deep-sea fish oil soft capsules containing Salvia root P.E | |
| EA028641B1 (en) | Edible lipid composition comprising stearidonic acid and olive oil | |
| CN103989176B (en) | Deep-sea fish oil soft capsules containing kudzu root extract | |
| JP7023732B2 (en) | Treatment or prevention of liver disease with inflammation | |
| CN103989175A (en) | Deep sea fish oil soft capsule containing apocynum venetum extract | |
| CN104082741A (en) | Soft seal oil capsule containing astaxanthin | |
| JP2006273788A (en) | Composition originating from ppar ligand activity-having plant | |
| CN103989185A (en) | Deep sea fish oil soft capsule containing coenzyme Q | |
| JP6892532B2 (en) | In vivo fatty acid content increasing agent | |
| CN103989178A (en) | Deep sea fish oil soft capsule containing ginkgo leaf oil | |
| CN104432032A (en) | Health food capable of reducing blood fat | |
| CN104920638A (en) | Health-care blend oil and preparation method thereof | |
| JP2007022917A (en) | Composition originating from plant having ppar ligand activity |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20141008 |